Abstract: Cesarean deliveries represent almost one third of US births. Given that repeat cesarean is the most common single indication for cesarean, trial of labor after cesarean (TOLAC) with subsequent vaginal birth after cesarean (VBAC) is an important mechanism to reduce the overall cesarean rate. The 2010 National Institutes of Health Conference found that one of the biggest barriers to VBAC is the lack of patient access to TOLAC. Many women who currently deliver by repeat cesarean would be candidates for a TOLAC. This manuscript will summarize the evidence on VBAC to help clinicians identify candidates, provide evidence-based counseling, and guide management of TOLAC.
Introduction
Cesarean deliveries are the most commonly performed surgical procedure in the United States with just over 1.3 million cesareans performed annually. 1 Although cesarean delivery is a safe procedure, it poses both immediate and long-term risks including implications for future pregnancies. As cesarean delivery rates remain high and continue to climb, the impact of multiple cesarean deliveries is becoming increasingly evident. Increasing the appropriate use of vaginal birth after cesarean (VBAC) is an important mechanism to reducing the overall cesarean delivery rate.
VBAC was first recommended by the National Institutes of Health (NIH) Consensus Conference in 1980 as a means to safely reduce the cesarean delivery rate. 2 As shown in Figure 1 , although it took almost a decade following the NIH Consensus Conference for VBAC to gain popularity, once it did, VBAC was effective at decreasing the overall cesarean delivery rate. In fact just looking at the impact of VBAC and not considering the primary cesarean rate, for every 1% increase in VBAC there is a 0.58% decrease in total cesarean, demonstrating the direct and important effect VBAC has on US cesarean delivery rates.
From 1990 to 1996 the VBAC rate increased from 19.9% to 28.3% with a mirrored decrease in the cesarean delivery rate from 22.7% to 20.7% over that same time period. 3, 6 This trend, however, was short lived. An amalgam of complex factors including concern that uterine rupture occurred at higher rates than initially expected, 7, 8 medical-legal pressures, patient and provider preferences, and organizational changes resulted in a rapid reduction in trials of labor after cesarean (TOLAC) and VBAC and a subsequent increase in cesarean delivery rates; soaring to the highest ever recorded in 2009 at 32.9%. All of this occurred despite the national goal outlined by Healthy People 2010 to reduce the cesarean delivery rate to 15% of births. 9 Since 2007 the cesarean delivery rate has plateaued and remained essentially unchanged at 32.7% to 32.9% for the last 6 years. 4 To renew the effort once again to decrease the cesarean delivery rate, the NIH reconvened a NIH Consensus Conference in 2010 on VBAC. Their conclusions and recommendations again found that TOLAC is a reasonable option for many pregnant women with 1 prior low transverse uterine incision, yet many women in the United States lack access to clinicians and facilities willing and able to offer a trial of labor. 10 This paper aims to summarize the evidence regarding TOLAC, outlining an evidence-based approach in identifying appropriate candidates, counseling patients on risks and benefits of TOLAC/VBAC, managing TOLAC, and finally summarizing the potential impact that could be achieved by increasing the availability and use of VBAC.
Professional Society Guidelines
Professional society guidelines are often used to define a reasonable scope of practice. For this reason it is helpful to FIGURE 1. Rates of vaginal birth after cesarean [vaginal birth after cesarean (VBAC)], total, repeat, and primary cesarean deliveries. [3] [4] [5] compare professional society's guidance regarding cesarean and VBAC. The American College of Obstetrics and Gynecology (ACOG), 11 the Society of Obstetricians and Gynecology of Canada (SOGC), 12 and the Royal College of Obstetricians and Gynecologists (RCOG) 13 all have issued statements on VBAC. Table 1 highlights comparisons from each society regarding candidates, counseling, and management of TOLAC. All 3 societies agree that women with 1 or 2 prior low transverse cesareans should be offered TOLAC and that antenatal counseling should be documented and include both maternal and perinatal risks involved with both elective repeat cesarean delivery and trial of labor. Specifically, the RCOG recommends women to be counseled that planned VBAC carries an 8/10,000 risk of their infant developing hypoxic-ischemic encephalopathy. 13 It is inevitable that some women with a prior cesarean delivery will require induction of labor for one indication or another. All 3 societies consider induction of labor an 
Counseling: Risks and Benefits of VBAC
Women desiring TOLAC should be counseled on both the risks and benefits of their desired route of delivery including risks of maternal and neonatal morbidity as well as implications for future deliveries.
MATERNAL OUTCOMES
Maternal risks associated with TOLAC include hysterectomy, hemorrhage, transfusion, uterine rupture, and death. 14 Table 2 summarizes the maternal morbidity and mortality associated with VBAC and compares this with repeat cesarean.
Although rare, elective repeat cesarean carries a significantly higher risk of maternal mortality with an absolute risk of 0.013% [95% confidence interval (CI), 0.004%-0.0042%] versus 0.004% (95% CI, 0.001%-0.0015%) for TOLAC. The fact that TOLAC has now been found to have significantly less risk of maternal death is a compelling reason to increase the availability of TOLAC for women with prior cesarean. A review of the literature found no significant difference in hemorrhage, infection, or hysterectomy although the evidence was low in strength. However, the review did suggest that the risk of transfusion may be increased at term for TOLAC with 4 studies consistently reporting higher risk. Interestingly, one of the 4 studies suggests that this effect at term may be modified by medical comorbidities (0.22 for TOLAC compared with 0.41 for elective repeat cesarean delivery among women with medical comorbidities; 0.1 for trial of labor compared with 0.1 for elective repeat cesarean delivery in low-risk women).
14 Further research is needed to understand the degree to which maternal morbidities are due to other medical complications.
UTERINE RUPTURE
Uterine rupture, defined as a complete separation of the uterine wall, is a serious and potentially catastrophic risk for women with a prior cesarean and has received substantial attention. The risk of uterine rupture in any woman with a prior cesarean scar is 0.3%. 14 Although the absolute risk of uterine rupture is low for both TOLAC and elective repeat cesarean (0.47% vs. 0.03%), the risks are significantly increased for women attempting TOLAC (RR 20.74; 95% CI, 9.77-44.02; P<0.001). Given the serious nature of uterine rupture, people have tried to develop algorithms to predict its occurrence. Although the prediction of uterine rupture remains elusive, individual factors have been identified to be associated with uterine rupture. Table 3 presents the risk of uterine rupture by incision type. Women with prior incisions through the uterine corpus (eg, classic incision, myomectomy, uterine body extension) have a marked increase in the risk of uterine rupture and are not candidates for VBAC.
DIRECTION OF SCAR AND RISK OF UTERINE RUPTURE
14 There are less data surrounding low vertical incisions, but the limited studies that have looked at uterine rupture rates in this setting have found a rupture rate of 1.05% to 2.0%. 14, 15 The quandary for clinicians who are managing a patient with a previous vertical incision is feeling confident that the incision does not extend beyond the lower uterine segment. Finally, because most women with unknown scars at term are likely to have a low transverse uterine scar, there is general agreement that an unknown scar is not a contraindication to TOLAC. 11 
OTHER FACTORS ASSOCIATED WITH RISK OF UTERINE RUPTURE
Other factors that have been identified to increase a woman's risk of uterine rupture are listed in Table 4 and briefly summarized below.
TWIN GESTATIONS
Two large population studies evaluated TOLAC in twin gestation and found no significant difference in uterine rupture risk (0.9% to 1.1% vs. 0.4% to 0.7%) when compared with singleton gestations. 15 On the basis of these data, ACOG recommends that women with twin gestation who are otherwise candidates for vaginal delivery be considered candidates for TOLAC.
11

FETAL MACROSOMIA
Fetal macrosomia is a common obstetrical condition affecting almost 10% of pregnancies in the United States. Although there are inconsistencies in how fetal macrosomia is defined (estimated fetal weight>4000 vs. 4500 g), studies do not show a statistically significant increased risk of uterine rupture but recognize that with increasing fetal weight there may be an associated increase in uterine rupture rates that is not yet proven due to the rarity of uterine rupture. 14 
MATERNAL OBESITY
Maternal obesity is a nationwide epidemic and carries its own risk for many obstetric complications including increased risk of cesarean section. The Maternal- Another population study of 300,000 women showed a 2-fold increase in uterine rupture rates when compared with women aged 25 to 29 years. Whereas, a study by Bujold et al 20 failed to demonstrate any increased rate of uterine rupture when women aged older than 35 were compared with their younger cohort. 14 
INTERPREGNANCY INTERVAL
Multiple studies have examined the effect of interpregnancy interval and associated risk of uterine rupture. The majority of the data indicate that there is an increased risk of uterine rupture 2-to 3-fold (OR, 2.05-2.65) with an interpregnancy interval of <24 months. 14 Counseling should mention that women with a short interval pregnancy may have a risk of uterine rupture that is >1%.
GESTATIONAL AGE >40 WEEKS
Pregnancies beyond 40 weeks' gestation have not been significantly shown to increase rates of uterine rupture in women undergoing TOLAC (1.1% vs. 1.0%). 14 It is important to remember that of the above-listed factors, previous classic cesarean section, >2 previous cesarean deliveries, and misoprostol administration are the only factors that are found to substantially increase the risk of uterine rupture to where VBAC should not be offered. All of the other listed factors have either not been extensively studied, have conflicting evidence, or are not statistically significant. Although these factors often enter into the counseling of patients, in general they should not exclude a patient from being offered TOLAC.
Not only is it important to review factors that elevate a woman's risk of uterine rupture, it is also important to mention the factors that reduce her risk, making TOLAC an even more attractive option. Prior vaginal delivery and prior VBAC reduce a woman's risk for uterine rupture in subsequent TOLAC, overall cutting the risk in half. Women who TOLAC after a prior vaginal delivery have uterine rupture rates significantly lower than women without a prior vaginal delivery (OR, 0.26 to 0.62).
14 Similarly, women with a prior VBAC have a reduced uterine rupture risk with an OR of 0.52 (CI, 0.34-0.82). 17 
NEONATAL OUTCOMES
Counseling in pregnancy always involves weighing maternal and neonatal risks and benefits. Table 5 Multiple studies have sought to understand the impact of TOLAC versus repeat cesarean on newborn respiratory conditions including transient tachypnea of the newborn and frequency of bag-and-mask ventilation. Neither of these conditions has been found to differ between TOLAC and elective repeat cesarean. Similarly, no difference has been found in hypoxic-ischemic encephalopathy or asphyxia, however, the number of studies and quality of studies is low for these outcomes. 
Counseling: Selecting Candidates for VBAC
One of the challenges in counseling patients with a prior cesarean delivery regarding TOLAC versus elective repeat cesarean is the inability to accurately predict those with a high likelihood of successful VBAC. This becomes important because the majority of the morbidity and mortality related to TOLAC is attributed to those who attempt TOLAC but do not deliver vaginally.
FACTORS INFLUENCING THE LIKELIHOOD OF VBAC
Several factors have been identified in the literature that either increase or decrease the likelihood of successful TOLAC (Table 6 ). One of the strongest predictors of VBAC is a previous vaginal delivery. The literature consistently shows that women who have delivered vaginally in the past go on to have successful VBACs at a much higher rate (almost a 3-fold difference) 21 when compared with women without a prior vaginal delivery. Other favorable factors for VBAC include spontaneous labor and nonrecurrent indications for primary cesarean. Women who present with cervical dilation >3 cm or in spontaneous labor are more likely to go on to deliver vaginally compared with women who require induction, especially with a nonfavorable cervix. Primary cesareans performed for nonreassuring fetal status or fetal malpresentation carry an estimated repeat cesarean delivery (also known as ''failed trail of labor'') risk similar to that of a nulliparous woman. 21 
FACTORS ASSOCIATED WITH DECREASED LIKELIHOOD OF VBAC
Studies indicate that racial and ethnic differences influence the likelihood of successful VBAC. When compared with whites, nonwhite Hispanics and African American's were 20% to 52% and 29% to 50%, respectively, less likely to have a successful VBAC.
14 The literature also Factors associated with increased probability of VBAC History of prior vaginal delivery/VBAC Nonrecurring indication for prior cesarean (ex: malpresentation) Spontaneous rupture of membranes or favorable cervix at time of presentation Factors associated with decreased probability of VBAC Obesity (BMI>30 kg/m 2 ) Advanced maternal age ( >35) Maternal comorbid conditions (eg, hypertension, diabetes) Gestational age >40 wk Estimated fetal weight >4000 g Hispanic ethnicity, African American race BMI indicates body mass index; VBAC, vaginal birth after cesarean.
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shows a decrease in the success rate of VBAC in the setting of macrosomia. Birth weight >4000 g is associated with nearly half the likelihood of VBAC compared with those with birth weight <4000 g (OR, 2.65) and this decreased likelihood becomes even more dramatic with increasing birth weight, (likelihood of VBAC success in infants >4000 g is 11.6% vs. >4500 g is 1.3%, P<0.001).
14
Of note, such studies have been done with actual birth weight, not estimated fetal weight so caution is needed before applying these findings directly to practice. Elevated BMI (BMI>30) significantly decreases likelihood for successful VBAC. The systematic review conducted for the NIH Consensus Conference 14 found a dose-dependent decrease in vaginal delivery rates as BMI increases (Fig. 2) . One of the best things maternal health providers can do to improve pregnancy outcomes is to help women retain normal body weight.
PREDICTIVE TOOLS
On average, 6 to 8 women of every 10 eligible women who attempt TOLAC (60% to 80%) will have a VBAC.
14 It would be ideal for clinicians to have a calculator that could predict likelihood of VBAC and risk for uterine rupture. This would make counseling much easier. Unfortunately, attempts to predict uterine rupture have not been successful. However, 2 predictive models developed by Grobman et al 22 to predict likelihood of VBAC one in early pregnancy and the other at the onset of labor, have been independently validated retrospectively in the United States, Japan, and The Netherlands, and are in need of prospective trials to understand their use in practice. Their results are promising in that almost half of women would be predicted to receive additional information to discriminate whether they have higher or lower chances than average for VBAC (27% would score >80% and almost 20% would score <60%). The validation study from The Netherlands found that counseling alone without predicted numbers may also have an effect. 23 What is not known is whether telling a patient that she has ''an 80% predicted success rate,'' ''a better than average success rate,'' or ''an FIGURE 2. Percent vaginal birth after cesarean following trial of labor by body mass index. 14, 18 80% success rate compared with an average of 70%'' leads to different or better decisions. Prospective studies are needed to understand the impact on patient decision making and outcomes.
Intrapartum Management
Whether presenting in spontaneous labor or for induction there are certain steps that should be performed to maximize the safety of both mother and fetus in women undergoing a TOLAC. Given our inability to predict if and when uterine rupture will occur, it is recommended that women undergoing a TOLAC undergo continuous fetal monitoring, IV placement, complete blood count, and type and screen. There have been no data to show that internal monitoring with an intrauterine pressure catheter has been shown to detect uterine rupture. 14 With almost 1 in 4 pregnant women being induced, 5 understanding evidence around induction of labor for women with prior cesarean is important. Induction of labor often requires cervical ripening, typically performed with misoprostol, prostaglandin E2, mechanical dilation, or oxytocin. Women with a prior uterine scar who undergo induction of labor, especially with prostaglandins, have been shown to have an increased rate of uterine rupture. 8, 14 The use of misoprostol for induction of labor in women with a prior uterine incision carries a risk of uterine rupture close to 6% and it thus is not recommended. 14 Prostaglandin E2 confers an increased rupture risk of 2% and oxytocin has the lowest rate of associated uterine rupture at 1.1%.
14 There are no data to indicate that mechanical dilation with a balloon confers any increased risk of uterine rupture, however, the evidence is limited.
14 Augmentation of labor with oxytocin, when studied separately from use in conjunction with cervical ripening agents again is varied. There is no clear association between the use of oxytocin for labor augmentation and increased risk of uterine rupture. 14 
Future Impact
In counseling patients about TOLAC or repeat cesarean, it is important to address the downstream ramifications of each. As the cesarean delivery rate continues to increase, it is becoming increasingly clear that multiple repeat cesareans carry substantial health risks. Table 7 summarizes the risks associated with increasing number of cesareans.
Cesarean deliveries increase the risk of abnormal placentation in future pregnancies including risk of placenta previa, placenta accreta, increta, and percreta. This spectrum of abnormal placentation holds significant maternal and neonatal morbidity including prolonged antepartum hospitalization, preterm delivery, need for emergent cesarean section, hysterectomy, blood transfusion, intensive care unit admission, and maternal and fetal death. Reducing Repeat Cesarean by Increasing VBAC 317
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Women with Z1 prior cesarean deliveries are at significantly increased risk for placenta previa by a rate of 1.2% (95% CI, 0.8-1.5) compared with women without a prior cesarean. This risk increases with increasing number of prior cesarean deliveries. In women with Z5 cesareans, the rate of placenta previa increases to close to 3.7%. 14 Women who have both a placenta previa and a prior cesarean section are at increased risk of placenta accreta compared with women without a prior cesarean. The risk of placenta accreta increases significantly with each cesarean section and the composite maternal morbidity and risk of mortality rises in the same manner. Thus, repeat cesarean holds important and potentially catastrophic risks, and providers play an important role in helping the woman understand these risks on both sides and helping them to understand the best balance and choice for their situation.
Summary
The rate of cesarean delivery in the United States, although stable, is lingering at record highs. The implications of increasing cesareans have yet to be fully appreciated but are clearly concerning. VBAC is a safe and effective mode of delivery for the majority of women with 1 or 2 prior low transverse uterine incisions. Although our predictive powers to know who will experience poor outcomes and who will succeed are poor, the majority of women (60% to 80%) who have a TOL-AC have a successful VBAC. With appropriate counseling and management, VBAC is an important mechanism to reduce the cesarean delivery rate in the United States.
